)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Apyx Medical
Apyx Medical (APYX) investor relations material
Apyx Medical Investor presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Investor presentation summary28 Aug, 2026
Market positioning and trends
Positioned as a leader in surgical aesthetics, focusing on minimally invasive procedures and capitalizing on the surge in demand following widespread GLP-1 drug adoption for weight loss.
Skin tightening is now the top requested treatment post-weight loss, with 72% of GLP-1 users citing loose skin as their main concern.
Only surgical procedures are seen as providing durable, transformational results, with a shift from noninvasive to surgical solutions.
Google Trends data shows rising interest in skin tightening and body contouring from 2023 to 2026.
Product innovation and clinical evidence
Renuvion is the only FDA-approved device for treating loose skin post-liposuction and for contracting subcutaneous soft tissue anywhere on the body.
AYON Body Contouring System received FDA clearance in May 2025, with expanded indications for power liposuction in May 2026.
Renuvion combines helium plasma and radiofrequency energy for rapid, effective skin contraction and neocollagenesis.
Over 120 clinical publications and two multi-site IDE studies support the safety and efficacy of Renuvion.
Financial performance and guidance
2026 revenue guidance is $59.0–$60.0 million, up from $52.8 million in 2025; Surgical Aesthetics revenue expected at $54.0–$55.0 million.
OEM revenue projected at $5.0 million for 2026, down from $7.5 million in 2025.
Operating expenses are expected to remain below $45.0 million in 2026.
Single-use handpiece sales accounted for about 50% of Surgical Aesthetics revenue in 2025.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Apyx Medical
- AYON’s launch leverages GLP-1-driven demand for surgical aesthetics and global expansion.APYX
Canaccord Genuity's 46th Annual Growth Conference - Q2 2026 revenue rose 22.1% to $13.9M, with margin gains and guidance reaffirmed.APYXQ2 2026
- Key votes on directors, auditor, executive pay, and a new incentive plan recommended for approval.APYXProxy filing
- FDA-cleared technologies and cost discipline drive growth in the expanding surgical aesthetics market.APYXInvestor presentation
- Q1 revenue up 32% to $12.5M, net loss narrowed, and FY2026 guidance raised.APYXQ1 2026
- Record revenue and AYON launch drive double-digit growth and improved profitability.APYXQ4 2025
- Q3 revenue up 12.1% to $12.9M, net loss narrows, and FY2025 guidance is raised.APYXQ3 2025
- Q3 revenue dropped 4% as cost cuts and new funding target improved 2025 performance.APYXQ3 2024
- Margins improved and net loss narrowed in Q4 2024 amid cost cuts and strong U.S. sales.APYXQ4 2024
Next Apyx Medical earnings date
Q3 20265 Nov, 2026
Apyx Medical
Next Apyx Medical earnings date
Q3 20265 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Apyx Medical Corporation is an advanced energy technology company that develops and manufactures products for the cosmetic surgery and healthcare markets. The company’s primary products include helium plasma technology devices, used for minimally invasive cosmetic procedures and surgical applications. Apyx Medical's devices are designed to enhance precision, reduce recovery times, and improve patient outcomes in procedures such as skin tightening and tissue coagulation. The company is headquartered in Clearwater, United States, and its shares are listed on the NASDAQ.